Enducef T 500mg/62.5mg Injection
Marketer
Endurance Healthcare Ltd
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Enducef T 500mg/62.5mg Injection
Cefixime and Sulbactam injection (500mg/62.5mg), sold as Enducef T, combats bacterial infections by inhibiting microbial growth and propagation. This combination medication requires administration by a healthcare provider. Complete the prescribed dosage; premature cessation may compromise efficacy. Regularly scheduled doses are crucial. Common side effects include nausea, vomiting, diarrhea, and indigestion. Worsening side effects necessitate immediate medical attention. Seek immediate medical assistance for allergic reactions (rash, itching, swelling, breathing difficulties). Disclose all current medications to your doctor before starting Enducef T. Pregnant or breastfeeding individuals should consult their physician. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration will aid recovery. Your doctor may order tests to monitor the medication's effects.
Uses of Enducef T 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Enducef T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Enducef T 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Enducef T 500mg/62.5mg Injection:
Administering this medication will be done by your physician or their associate; self-medication is strictly prohibited.
How Enducef T 500mg/62.5mg Injection works:
Enducef T, a 500mg/62.5mg injectable formulation, unites Ceftriaxone, a third-generation cephalosporin antibiotic, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby amplifying Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Enducef T 500mg/62.5mg Injection and alcohol is not associated with adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Enducef T (500mg/62.5mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Enducef T 500mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Enducef T 500mg/62.5mg Injection may cause drowsiness, blurred vision, and dizziness. Driving is inadvisable if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Enducef T 500mg/62.5mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The use of Enducef T 500mg/62.5mg Injection requires careful consideration in individuals with severe hepatic impairment, potentially necessitating dosage modification. A physician's consultation is advised. Dosage alteration for Enducef T 500mg/62.5mg Injection is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Enducef T 500mg/62.5mg Injection :
Omitting a scheduled dose of Enducef T 500mg/62.5mg Injection warrants immediate physician consultation.
Facts to Know About Enducef T 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
3,018 People bought this recently